TEL fusion proteins with other tyrosine kinases, such as ABL1, ABL2, JAK2, NTRK3, FFGR3, and PDGFRB, have also been associated with various hematologic malignancies [6], [15], though direct comparisons between these fusion proteins in mouse models is not complete. Here, ABL2 is linked to hematologic disorder.